When peripheral artery disease (PAD) progresses to Chronic Limb-Threatening Ischemia (CLTI), a patient’s options become limited. As the disease evolves to its late stages, patients may no longer be candidates for balloons or stents and may face bypass surgery, or worse, amputation.
However, they are ready to do anything to resolve the pain and regain quality of life.
Enter LimFlow and the investigational LimFlow System.
In a minimally-invasive fashion, the LimFlow System is designed to bypass blocked arteries in the leg and rush blood back into the foot, potentially avoiding major amputation, resolving pain and promoting wound healing.
The PROMISE II trial is now enrolling nationwide: https://limflow.com/us/us-promise-ii-clinical-trial/
CAUTION: Investigational device. Limited by Federal law to investigational use.
However, they are ready to do anything to resolve the pain and regain quality of life.
Enter LimFlow and the investigational LimFlow System.
In a minimally-invasive fashion, the LimFlow System is designed to bypass blocked arteries in the leg and rush blood back into the foot, potentially avoiding major amputation, resolving pain and promoting wound healing.
The PROMISE II trial is now enrolling nationwide: https://limflow.com/us/us-promise-ii-clinical-trial/
CAUTION: Investigational device. Limited by Federal law to investigational use.
Location: France, Ile-de-France, Paris
Employees: 11-50
Total raised: $33M
Founded date: 2012
Investors 3
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| - | MD Start A... | mdstart.eu |
| 27.04.2022 | Longitude ... | longitudec... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.04.2018 | Series C | $33M | - |
Mentions in press and media 6
| Date | Title | Description |
| 25.06.2025 | Dr. Katherine MacCallum First in Rhode Island to Perform Limb-Saving Limflow® TADV Procedure | Breakthrough procedure reduces amputation risk for patients with Chronic Limb-Threatening Ischemia We’re not only saving legs–we’re enabling these patients to retain their independence, lessen the need for prolonged hospital and rehabilitat... |
| 06.04.2022 | LimFlow scores $40M Series D | Paris-based LimFlow has raised $40 million from investors including Longitude Capital, Soleus Capital Management and Sofinnova Partners. The startup is developing minimally invasive technology designed to restore blood flow to lower limbs i... |
| 17.04.2018 | Term Sheet — Tuesday April 17 | What Trident Capital’s First Female Partner Thinks We Need in VC Good morning, Term Sheet Readers. Paid Content Securing the enterprise without boundaries From ExtraHop The RSA Conference, the computer security industry’s biggest confab, ki... |
| 16.04.2018 | LimFlow Raises $33.M in Series C Financing | LimFlow SA, a Paris, France-based developer of peripheral endovascular technology, raised $33.5m in Series C financing. The round was led by Sofinnova Partners with participation from Bpifrance, the French Sovereign investment bank and Bale... |
| 13.10.2016 | Medtronic-supported European medtech accelerator raises $11.5M | The money will be invested from MD Start II, and four medical device companies will be incubated and managed by partners at the accelerator. “MD Start II is not another fund, nor another incubator: MD Start II is the entrepreneur as well as... |
| - | Medtronic-supported European medtech accelerator raises $11.5M | MD Start, a European medical technology accelerator, announced Thursday that it has raised $11.5 million to create and fund four new French companies that can fulfill unmet needs in the medical device market. The round was led by French Tec... |